Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mRNA Display in Cell Lysates Enables Identification of Cyclic Peptides Targeting the BRD3 Extraterminal Domain. | Angew Chem Int Ed Engl | 2024 | 38899853 | PubTator, text mining | PubMed |
| Oligomerization of drug transporters: Forms, functions, and mechanisms. | Acta Pharm Sin B | 2024 | 38799641 | PubTator, text mining | PubMed |
| Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases. | J Transl Med | 2024 | 38685026 | PubTator, text mining | PubMed |
| Inhibitors to degraders: Changing paradigm in drug discovery. | iScience | 2024 | 38646175 | PubTator, text mining | PubMed |
| Attraction and disruption: how loop extrusion and compartmentalisation shape the nuclear genome. | Curr Opin Genet Dev | 2024 | 38636335 | PubTator, text mining | PubMed |
| BRD2 promotes antibody class switch recombination by facilitating DNA repair in collaboration with NIPBL. | Nucleic Acids Res | 2024 | 38567724 | PubTator, text mining | PubMed |
| Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases. | J Pharmacol Exp Ther | 2024 | 38565308 | PubTator, text mining | PubMed |
| Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond. | Cells | 2024 | 38474390 | PubTator, text mining | PubMed |
| miR-143 promotes cell proliferation, invasion and migration via directly binding to BRD2 in lens epithelial cells. | Am J Transl Res | 2024 | 38463605 | PubTator, text mining | PubMed |
| Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. | iScience | 2024 | 38439961 | PubTator, text mining | PubMed |
| Targeted protein degradation via intramolecular bivalent glues. | Nature | 2024 | 38383787 | PubTator, text mining | PubMed |
| Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. | Pharm Res | 2024 | 38366233 | PubTator, text mining | PubMed |
| How Competition for Funding Impacts Scientific Practice: Building Pre-fab Houses but no Cathedrals. | Sci Eng Ethics | 2024 | 38349578 | PubTator, text mining | PubMed |
| Epigenetic regulators controlling osteogenic lineage commitment and bone formation. | Bone | 2024 | 38341164 | PubTator, text mining | PubMed |
| The Dynamics of Histone Modifications during Mammalian Zygotic Genome Activation. | Int J Mol Sci | 2024 | 38338738 | PubTator, text mining | PubMed |
| In vitro cytotoxicity of Withania somnifera (L.) roots and fruits on oral squamous cell carcinoma cell lines: a study supported by flow cytometry, spectral, and computational investigations. | Front Pharmacol | 2024 | 38303989 | PubTator, text mining | PubMed |
| Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours. | Clin Transl Med | 2024 | 38303608 | PubTator, text mining | PubMed |
| BCL7A and BCL7B potentiate SWI/SNF-complex-mediated chromatin accessibility to regulate gene expression and vegetative phase transition in plants. | Nat Commun | 2024 | 38296999 | PubTator, text mining | PubMed |
| Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. | bioRxiv | 2024 | 38293113 | PubTator, text mining | PubMed |
| Novel BRD2::NUTM1 Fusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report. | JTO Clin Res Rep | 2024 | 38287941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=7